Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)
Treace Medical Concepts' (TMCI) quarterly Preferred Shares came in at $7.9 million in Q1 2021, little changed quarter-over-quarter from $7.9 million in Q4 2020.
Analysis
Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Preferred Shares for 2 consecutive years, with $7.9 million the latest figure, recorded in Q1 2021.
- For the quarter ending Q1 2021, Preferred Shares changed N/A year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2021 stood at $7.9 million (changed N/A YoY), and the FY2020 full-year result was $7.9 million, changed N/A from the prior year.
- Preferred Shares was little changed at $7.9 million in Q1 2021 per TMCI's latest filing, from $7.9 million in the prior quarter.
- Across five years, Preferred Shares topped out at $7.9 million in Q4 2020 and bottomed at $7.9 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | - |